AC
Ascento-CDA is developing a digital health platform that utilizes AI and machine learning to provide personalized disease management strategies for cognitive decline, dementia, and Alzheimer's disease. By conducting root-cause analysis of immunologic and inflammatory pathways, the platform generates evidence-based therapeutic guidelines for clinicians to address underlying conditions that contribute to cognitive decline.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Ascento-CDA is developing a digital health platform that utilizes AI and machine learning to provide personalized disease management strategies for cognitive decline, dementia, and Alzheimer's disease. By conducting root-cause analysis of immunologic and inflammatory pathways, the platform generates evidence-based therapeutic guidelines for clinicians to address underlying conditions that contribute to cognitive decline.